Sign in
Systemic therapy in pancreatic ductal adenocarcinoma: Does drug selection, sequence, and duration impact survival
Journal article   Open access  Peer reviewed

Systemic therapy in pancreatic ductal adenocarcinoma: Does drug selection, sequence, and duration impact survival

A.A. Javed, A. Noor, J.G. Sham, A. Hasanain, A.B. Blair, M.J. Wright, N. Rozich, D. Ho, J.L. Cameron, J. He, …
HPB (Oxford, England), Vol.22, pp.S71-S71
2020
url
https://doi.org/10.1016/j.hpb.2020.04.536View
Published (Version of record) Open

Metrics

1 Record Views

Details